General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic
- PMID: 35674639
- PMCID: PMC9674441
- DOI: 10.1097/DER.0000000000000908
General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic
Abstract
Background: Few studies have investigated health-related quality of life (HRQoL) in patients with atopic dermatitis (AD) during the COVID-19 pandemic.
Objectives: The objectives of this study were to compare HRQoL in adult AD patients before and during the pandemic and to assess measurement performance of 4 HRQoL measures.
Methods: Between 2018 and 2021, a multicenter, cross-sectional survey was conducted, involving 218 adult AD patients. Health-related quality of life outcomes included the EQ-5D-5L, Skindex-16, Dermatology Life Quality Index (DLQI), and DLQI-Relevant (DLQI-R). Severity was measured using objective SCORing Atopic Dermatitis, Eczema Area and Severity Index, and Investigator Global Assessment.
Results: The mean ± SD EQ-5D-5L utility, Skindex-16, DLQI, and DLQI-R scores were 0.82 ± 0.22, 56.84 ± 27.46, 13.44 ± 8.46, and 13.76 ± 8.60, respectively. The patients reported more problems during the pandemic ( P < 0.05) regarding pain/discomfort (odds ratio [OR], 1.78), worrying (OR, 1.89), concerns about persistence/reoccurrence of disease (OR, 1.88), and social relationships (OR, 1.69). The HRQoL outcomes showed strong correlations with each other (range of rs , |0.69| to |0.99|). The Skindex-16, DLQI, and DLQI-R were able to discriminate between severity groups with large (η 2 = 0.20-0.23), whereas the EQ-5D-5L with moderate effect sizes (η 2 = 0.08-0.11).
Conclusions: Atopic dermatitis patients experienced significantly more problems in some areas of HRQoL during the pandemic. The EQ-5D-5L, Skindex-16, DLQI, and DLQI-R demonstrated good convergent and known-group validity and can be suitable instruments for HRQoL assessment in clinical and research settings.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Contact Dermatitis Society.
Conflict of interest statement
Related to this work, M.S. has received support for travel to meetings for the study or other purposes from Lilly. Outside the submitted work, M.S. has received fees for board membership, consultancy, or lecturing from Janssen, Sanofi, Egis, Novartis, Leo Pharma, and Lilly. Outside the submitted work, A.S. has received fees for board membership or lecturing from Janssen, AbbVie, Lilly, and Sanofi. F.R. is a member of the EuroQol Group. Views expressed in the article are those of the authors and are not necessarily those of the EuroQol Research Foundation. K.K.'s work was supported by the Semmelweis 250+ Excellence PhD Scholarship (EFOP-3.6.3-VEKOP-16-2017-00009). Á.S.'s work was supported by the Higher Education Institutional Excellence Program 2020 of the Ministry of Innovation and Technology in the framework of the 'Financial and Public Services' research project (TKP2020-IKA-02) at the Corvinus University of Budapest. F.R.'s work was supported by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00304/21) and the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund (ÚNKP-21-5-CORVINUS-134). The other authors have no conflicts of interest to declare.
Figures

Similar articles
-
Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2584-2592. doi: 10.1111/jdv.16642. Epub 2020 Jul 2. J Eur Acad Dermatol Venereol. 2020. PMID: 32618022
-
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.Eur J Health Econ. 2023 Feb;24(1):139-152. doi: 10.1007/s10198-022-01460-y. Epub 2022 Apr 12. Eur J Health Econ. 2023. PMID: 35412162 Free PMC article.
-
Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study.Qual Life Res. 2020 Sep;29(9):2529-2539. doi: 10.1007/s11136-020-02499-1. Epub 2020 Apr 15. Qual Life Res. 2020. PMID: 32297132 Free PMC article.
-
The Psychosocial Impact of Atopic Dermatitis.Adv Exp Med Biol. 2024;1447:69-81. doi: 10.1007/978-3-031-54513-9_7. Adv Exp Med Biol. 2024. PMID: 38724785 Review.
-
Psychological assessment of atopic dermatitis in Asia: a systematic review.Psychol Health Med. 2023 Jan;28(1):1-26. doi: 10.1080/13548506.2021.1971727. Epub 2022 Jan 10. Psychol Health Med. 2023. PMID: 35000520
Cited by
-
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review.J Eur Acad Dermatol Venereol. 2025 Mar;39(3):631-679. doi: 10.1111/jdv.20321. Epub 2024 Sep 13. J Eur Acad Dermatol Venereol. 2025. PMID: 39269008 Free PMC article.
-
Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia-Pacific Region: A Cross-sectional Survey.Dermatol Ther (Heidelb). 2024 Sep;14(9):2479-2493. doi: 10.1007/s13555-024-01244-7. Epub 2024 Aug 5. Dermatol Ther (Heidelb). 2024. PMID: 39103673 Free PMC article.
-
Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates.Cureus. 2024 Sep 19;16(9):e69764. doi: 10.7759/cureus.69764. eCollection 2024 Sep. Cureus. 2024. PMID: 39429316 Free PMC article. Review.
-
Societal costs and health related quality of life in adult atopic dermatitis.BMC Health Serv Res. 2023 Aug 14;23(1):859. doi: 10.1186/s12913-023-09840-7. BMC Health Serv Res. 2023. PMID: 37580792 Free PMC article.
-
Impact of COVID-19 pandemic on adults and children with atopic dermatitis and food allergy: Systematic review.J Allergy Clin Immunol Glob. 2023 Oct 18;3(1):100181. doi: 10.1016/j.jacig.2023.100181. eCollection 2024 Feb. J Allergy Clin Immunol Glob. 2023. PMID: 38026506 Free PMC article.
References
-
- Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020;396:345–360. - PubMed
-
- Birdi G, Cooke R, Knibb RC. Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis. Int J Dermatol 2020;59:e75–e91. - PubMed
-
- Gabes M, Tischer C, Apfelbacher C. Measurement properties of quality-of-life outcome measures for children and adults with eczema: an updated systematic review. Pediatr Allergy Immunol 2020;31:66–77. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical